Firefly Neuroscience, Inc. (AIFF) Dividend History

Firefly Neuroscience, Inc. is a biotechnology company focused on developing innovative neural interface technologies. The company aims to create products that facilitate communication between the brain and electronic devices, with a focus on advancing treatments for neurological disorders and enhancing human capabilities through neurotechnology.

12015 Lee Jackson Memorial Hwy, Fairfax, VA, 22033
Phone: (703) 383-3000
Website: https://www.fireflyneuro.com

Dividend History

Firefly Neuroscience, Inc. currently does not pay dividends

Company News

Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc.

Firefly Neuroscience, an AI company, has acquired Evoke Neuroscience, a medical device company, to expand its proprietary database, patent portfolio, and commercial reach. The acquisition marks a significant step towards Firefly's goal of building a foundation model of the human brain.

Benzinga
Firefly Neuroscience Announces Exercise of Warrants for Total Proceeds of $8.8 Million

Firefly Neuroscience, Inc. has received $8.8 million from the exercise of warrants, which will be used for general working capital purposes, including the development of its FDA-cleared Brain Network Analytics (BNA™) technology platform.

GlobeNewswire Inc.
Firefly Neuroscience Accepted into NVIDIA Connect Program

Firefly Neuroscience, an AI company developing solutions for brain health, has been accepted into the NVIDIA Connect program. This will provide Firefly with technical resources to support its initiative to build a proprietary foundation model of the human brain using its FDA-cleared BNA™ technology platform.

GlobeNewswire Inc.

Featured Companies: NVDA
Firefly Neuroscience Reports Third Quarter 2024 Results and Provides Stockholder Update

Firefly Neuroscience, a Nasdaq-listed AI company, announced its Q3 2024 financial results and provided updates on its partnerships with pharmaceutical companies like Bright Minds Bioscience, Novartis, and Takeda to advance its Brain Network Analytics (BNA) technology for neurological and mental disorder treatments.

GlobeNewswire Inc.

Featured Companies: DRUG
4 Biotech Stocks With AI, Machine Learning Prowess

The article discusses four biotech companies leveraging AI and machine learning technology to improve drug discovery and development processes. These companies are Absci, Firefly Neuroscience, Korro Bio, and NeuroSense Therapeutics.

Investing.com

Featured Companies: ABSI KRRO NRSN

Dividend data last updated 06/07/2025 07:18:32 UTC